Humacyte’s mission is to become the leading company in novel, off-the-shelf extracellular matrix tissue products, and especially those that could provide lifesaving improvements in treatments for vascular conditions. Because we grow these tissue replacements in vitro from banked vascular cells that are decellularized, our products do not require cells from the patient and can be easily stored until patients and their surgeons need them.
